Market Estimates
Valuation Metrics
Financials
Trading Trends
BBIO News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is BridgeBio Pharma Inc (BBIO) stock price today?
The current price of BBIO is 77.25 USD — it has increased 4.65 % in the last trading day.
What is BridgeBio Pharma Inc (BBIO)'s business?
BridgeBio Pharma, Inc. is a biopharmaceutical company. It discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases. Its pipeline of development programs ranges from early science to advanced clinical trials, which includes Attruby, an oral small molecule near-complete transthyretin (TTR) stabilizer, for the treatment of cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM); Beyonttra for the treatment of TTR Amyloidosis; Low-dose Infigratinib, an oral FGFR1-3 selective tyrosine kinase inhibitor (TKI) for the treatment of children with achondroplasia and hypochondroplasia; Encaleret, an oral small molecule antagonist of the calcium sensing receptor (CaSR) that it is developing for the treatment of Autosomal Dominant Hypocalcemia Type 1 (ADH1), and BBP-418, for the treatment of Limb Girdle Muscular Dystrophy Type 2I. It also conducting a Phase 1/2 study (CANaspire) for BBP-812 for Canavan disease.
What is the price predicton of BBIO Stock?
Wall Street analysts forecast BBIO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BBIO is 84.20 USD with a low forecast of 64.00 USD and a high forecast of 100.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is BridgeBio Pharma Inc (BBIO)'s revenue for the last quarter?
BridgeBio Pharma Inc revenue for the last quarter amounts to 120.70M USD, increased 4318.01 % YoY.
What is BridgeBio Pharma Inc (BBIO)'s earnings per share (EPS) for the last quarter?
BridgeBio Pharma Inc. EPS for the last quarter amounts to -0.95 USD, increased 10.47 % YoY.
What changes have occurred in the market's expectations for BridgeBio Pharma Inc (BBIO)'s fundamentals?
How many employees does BridgeBio Pharma Inc (BBIO). have?
BridgeBio Pharma Inc (BBIO) has 725 emplpoyees as of January 11 2026.
What is BridgeBio Pharma Inc (BBIO) market cap?
Today BBIO has the market capitalization of 14.89B USD.


![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20260106220114_357efc7d1f3fd665b66477cc17a1f3e5.jpg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20260102213124_06390f6163fd5e52a3c8ca655476a80d.png&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fdefault_image%2Fbarrons.png&w=384&q=75)